(VXX) iPath Series SP500 VIX - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US06748F3249 • Trading--Miscellaneous
VXX: Futures, Contracts, Volatility, Index
The iPath® Series B S&P 500® VIX Short-Term Futures ETN (VXX) is a financial instrument designed to provide investors with exposure to the S&P 500 VIX Short-Term Futures index. This index tracks the performance of futures contracts on the CBOE Volatility Index (VIX), often referred to as the fear gauge of the stock market. Unlike direct exposure to the VIX spot index, VXX offers a way to gain exposure to the futures contracts of specified maturities, which can behave differently from the spot price due to factors like contango and roll yield. The ETN is structured as a senior, unsecured debt instrument issued by Barclays Bank PLC.
As a trading tool, VXX is widely used by investors seeking to hedge against market downturns or speculate on short-term market volatility. It is important to note that VXX is not designed for long-term holding due to the potential negative impact of rolling futures contracts in a contangoed market structure. The ETNs performance can diverge significantly from the VIX spot index over extended periods.
Based on the provided data, here is a 3-month forecast for VXX:
Month 1: The price of VXX is likely to test the lower end of its support range (43.9) if market stability persists. The 20-day SMA (43.35) and 50-day SMA (44.42) suggest downward momentum, with average daily volume (6,512,041 shares) indicating moderate liquidity. ATR (2.28) points to limited near-term volatility.
Month 2: If market conditions remain calm, VXX could consolidate near its current price level (46.57). The 200-day SMA (47.19) may act as a ceiling, while the lower support levels (43.9) could provide a floor. AUM of $448.69M reflects moderate investor interest.
Month 3: A potential increase in market volatility could drive VXX toward its resistance levels (47.8 to 56.9). The ATR (2.28) suggests that price movements could remain contained unless broader market conditions shift significantly. The ETNs performance will largely depend on the shape of the VIX futures curve and investor demand for hedging.
Additional Sources for VXX ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VXX ETF Overview
| Market Cap in USD | 622m |
| Category | Trading--Miscellaneous |
| TER | 0.89% |
| IPO / Inception | 2018-01-17 |
VXX ETF Ratings
| Growth Rating | -75.4 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 1.38 |
| Analysts | - |
| Fair Price Momentum | 40.71 USD |
| Fair Price DCF | - |
VXX Dividends
No Dividends PaidVXX Growth Ratios
| Growth Correlation 3m | 83.7% |
| Growth Correlation 12m | -3.6% |
| Growth Correlation 5y | -98% |
| CAGR 5y | -51.29% |
| CAGR/Max DD 5y | -0.52 |
| Sharpe Ratio 12m | -1.18 |
| Alpha | -26.36 |
| Beta | 9.020 |
| Volatility | 182.28% |
| Current Volume | 8333.5k |
| Average Volume 20d | 7100.1k |
As of April 16, 2025, the stock is trading at USD 68.32 with a total of 8,333,514 shares traded.
Over the past week, the price has changed by -20.02%, over one month by +37.99%, over three months by +56.88% and over the past year by +9.42%.
No, based on ValueRay Analyses, iPath Series SP500 VIX (BATS:VXX) is currently (April 2025) a stock to sell. It has a ValueRay Growth Rating of -75.42 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VXX as of April 2025 is 40.71. This means that VXX is currently overvalued and has a potential downside of -40.41%.
iPath Series SP500 VIX has no consensus analysts rating.
According to ValueRays Forecast Model, VXX iPath Series SP500 VIX will be worth about 48.9 in April 2026. The stock is currently trading at 68.32. This means that the stock has a potential downside of -28.5%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.9 | -28.5% |